Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
Leslie CitromePedro SuchMurat YildirimJessica Madera-McDonoughClodagh BeckhamZhen ZhangFrank LarsenMatthew HarlinPublished in: The Journal of clinical psychiatry (2023)
Trial Registration: ClinicalTrials.gov identifier: NCT04030143.